These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 9184210

  • 1. Activation of the JNK pathway is essential for transformation by the Met oncogene.
    Rodrigues GA, Park M, Schlessinger J.
    EMBO J; 1997 May 15; 16(10):2634-45. PubMed ID: 9184210
    [Abstract] [Full Text] [Related]

  • 2. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
    Fixman ED, Naujokas MA, Rodrigues GA, Moran MF, Park M.
    Oncogene; 1995 Jan 19; 10(2):237-49. PubMed ID: 7838524
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.
    Besser D, Bardelli A, Didichenko S, Thelen M, Comoglio PM, Ponzetto C, Nagamine Y.
    Oncogene; 1997 Feb 13; 14(6):705-11. PubMed ID: 9038378
    [Abstract] [Full Text] [Related]

  • 4. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.
    Bardelli A, Basile ML, Audero E, Giordano S, Wennström S, Ménard S, Comoglio PM, Ponzetto C.
    Oncogene; 1999 Feb 04; 18(5):1139-46. PubMed ID: 10022119
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK, Langdon WY, Varticovski L.
    Oncogene; 1997 May 08; 14(18):2217-28. PubMed ID: 9174058
    [Abstract] [Full Text] [Related]

  • 6. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.
    Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G, Comoglio PM.
    Cell; 1994 Apr 22; 77(2):261-71. PubMed ID: 7513258
    [Abstract] [Full Text] [Related]

  • 7. Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein.
    Fixman ED, Fournier TM, Kamikura DM, Naujokas MA, Park M.
    J Biol Chem; 1996 May 31; 271(22):13116-22. PubMed ID: 8662733
    [Abstract] [Full Text] [Related]

  • 8. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S, Couvillon AD, Brasher BB, Van Etten RA.
    EMBO J; 2001 Dec 03; 20(23):6793-804. PubMed ID: 11726515
    [Abstract] [Full Text] [Related]

  • 9. Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.
    Gupta RW, Mayer BJ.
    Oncogene; 1998 Oct 29; 17(17):2155-65. PubMed ID: 9811447
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
    Mood K, Saucier C, Ishimura A, Bong YS, Lee HS, Park M, Daar IO.
    J Cell Physiol; 2006 Apr 29; 207(1):271-85. PubMed ID: 16331688
    [Abstract] [Full Text] [Related]

  • 11. Interactive roles of Ras, insulin receptor substrate-1, and proteins with Src homology-2 domains in insulin signaling in Xenopus oocytes.
    Chuang LM, Hausdorff SF, Myers MG, White MF, Birnbaum MJ, Kahn CR.
    J Biol Chem; 1994 Nov 04; 269(44):27645-9. PubMed ID: 7961682
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2.
    Husson H, Mograbi B, Schmid-Antomarchi H, Fischer S, Rossi B.
    Oncogene; 1997 May 15; 14(19):2331-8. PubMed ID: 9178909
    [Abstract] [Full Text] [Related]

  • 15. Nerve growth factor induced stimulation of Ras requires Trk interaction with Shc but does not involve phosphoinositide 3-OH kinase.
    Hallberg B, Ashcroft M, Loeb DM, Kaplan DR, Downward J.
    Oncogene; 1998 Aug 13; 17(6):691-7. PubMed ID: 9715270
    [Abstract] [Full Text] [Related]

  • 16. A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
    Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ.
    Nature; 1996 Feb 08; 379(6565):560-4. PubMed ID: 8596638
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PH.
    Oncogene; 2002 Aug 22; 21(37):5684-95. PubMed ID: 12173038
    [Abstract] [Full Text] [Related]

  • 19. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
    Gishizky ML, Cortez D, Pendergast AM.
    Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):10889-93. PubMed ID: 7479904
    [Abstract] [Full Text] [Related]

  • 20. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.
    Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D.
    Nature; 1993 May 06; 363(6424):83-5. PubMed ID: 8479540
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.